Crossmark Global Holdings’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-5,820
Closed -$291K 1442
2021
Q2
$291K Buy
5,820
+10
+0.2% +$448 0.01% 1187
2021
Q1
$268K Buy
5,810
+590
+11% +$28.2K 0.01% 1233
2020
Q4
$224K Buy
+5,220
New +$198K 0.01% 1260
2019
Q4
Sell
-6,200
Closed -$341K 1448
2019
Q3
$341K Sell
6,200
-30
-0.5% -$1.72K 0.01% 990
2019
Q2
$311K Sell
6,230
-680
-10% -$33.8K 0.01% 1082
2019
Q1
$390K Buy
6,910
+160
+2% +$9.53K 0.01% 974
2018
Q4
$430K Buy
6,750
+80
+1% +$5.67K 0.01% 843
2018
Q3
$542K Buy
6,670
+230
+4% +$16.8K 0.01% 906
2018
Q2
$411K Buy
+6,440
New +$316K 0.01% 1091

Other funds holding TRHC

Crossmark Global Holdings's TRHC Position: Q3 2021 in Review

Crossmark Global Holdings sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q3 2021, closing a stake of 5,820 shares — an estimated $291K sold.

Crossmark Global Holdings first reported a position in TRHC in Q2 2018 and held it in 9 quarters. The position peaked at $542K in Q3 2018. 152 funds tracked by Wall St. Rank hold TRHC as of Q3 2021.

  • Crossmark Global Holdings reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Crossmark Global Holdings sold 5,820 Tabula Rasa HealthCare, Inc. Common Stock shares in Q3 2021, an estimated $291K.
  • Crossmark Global Holdings first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q2 2018 and held it in 9 quarters.
  • Crossmark Global Holdings's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $542K in Q3 2018.
  • 152 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q3 2021.

Based on Crossmark Global Holdings's 13F filing for Q3 2021, filed 13 Oct 2021.